These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 17637110

  • 41. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP.
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [Abstract] [Full Text] [Related]

  • 42. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells.
    Ifergan I, Kébir H, Bernard M, Wosik K, Dodelet-Devillers A, Cayrol R, Arbour N, Prat A.
    Brain; 2008 Mar; 131(Pt 3):785-99. PubMed ID: 18156156
    [Abstract] [Full Text] [Related]

  • 43. (Peri)vascular production and action of pro-inflammatory cytokines in brain pathology.
    Konsman JP, Drukarch B, Van Dam AM.
    Clin Sci (Lond); 2007 Jan; 112(1):1-25. PubMed ID: 17132137
    [Abstract] [Full Text] [Related]

  • 44. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium.
    Vestweber D.
    Immunol Rev; 2007 Aug; 218():178-96. PubMed ID: 17624953
    [Abstract] [Full Text] [Related]

  • 45. Going against the tide--how encephalitogenic T cells breach the blood-brain barrier.
    Lyck R, Engelhardt B.
    J Vasc Res; 2012 Aug; 49(6):497-509. PubMed ID: 22948545
    [Abstract] [Full Text] [Related]

  • 46. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis.
    Taoufik E, Tseveleki V, Euagelidou M, Emmanouil M, Voulgari-Kokota A, Haralambous S, Probert L.
    Neurodegener Dis; 2008 Aug; 5(1):32-7. PubMed ID: 18075273
    [Abstract] [Full Text] [Related]

  • 47. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF, Martin R.
    Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
    [Abstract] [Full Text] [Related]

  • 48. B- and T-cell responses in multiple sclerosis: novel approaches offer new insights.
    Hohlfeld R, Meinl E, Dornmair K.
    J Neurol Sci; 2008 Nov 15; 274(1-2):5-8. PubMed ID: 18707694
    [Abstract] [Full Text] [Related]

  • 49. DNA-based vaccines: the future of multiple sclerosis therapy?
    Stüve O, Cravens PD, Eagar TN.
    Expert Rev Neurother; 2008 Mar 15; 8(3):351-60. PubMed ID: 18345967
    [Abstract] [Full Text] [Related]

  • 50. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA, Millward JM, Owens T.
    J Neuroimmunol; 2007 Nov 15; 191(1-2):79-85. PubMed ID: 17920696
    [Abstract] [Full Text] [Related]

  • 51. [Immunological aspects of multiple sclerosis].
    Miyagishi R, Fukaura H, Fukazawa T, Tashiro K.
    No To Shinkei; 1993 Oct 15; 45(10):917-24. PubMed ID: 8268031
    [No Abstract] [Full Text] [Related]

  • 52. The effects of methylprednisolone and mitoxantrone on CCL5-induced migration of lymphocytes in multiple sclerosis.
    Jalosinski M, Karolczak K, Mazurek A, Glabinski A.
    Acta Neurol Scand; 2008 Aug 15; 118(2):120-5. PubMed ID: 18336625
    [Abstract] [Full Text] [Related]

  • 53. Mechanisms of lymphocyte migration in autoimmune disease.
    Norman MU, Hickey MJ.
    Tissue Antigens; 2005 Sep 15; 66(3):163-72. PubMed ID: 16101827
    [Abstract] [Full Text] [Related]

  • 54. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL, Wiendl H.
    Hum Immunol; 2008 Nov 15; 69(11):797-804. PubMed ID: 18723060
    [Abstract] [Full Text] [Related]

  • 55. Molecular mechanism of systemic delivery of neural precursor cells to the brain: assembly of brain endothelial apical cups and control of transmigration by CD44.
    Rampon C, Weiss N, Deboux C, Chaverot N, Miller F, Buchet D, Tricoire-Leignel H, Cazaubon S, Baron-Van Evercooren A, Couraud PO.
    Stem Cells; 2008 Jul 15; 26(7):1673-82. PubMed ID: 18450824
    [Abstract] [Full Text] [Related]

  • 56. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.
    Sellebjerg F, Sørensen TL.
    Brain Res Bull; 2003 Aug 15; 61(3):347-55. PubMed ID: 12909304
    [Abstract] [Full Text] [Related]

  • 57. Immunologic aspects of multiple sclerosis.
    Taylor RS.
    Phys Med Rehabil Clin N Am; 1998 Aug 15; 9(3):525-36, v. PubMed ID: 9894106
    [Abstract] [Full Text] [Related]

  • 58. Immunopathogenesis of multiple sclerosis.
    Agrawal SM, Yong VW.
    Int Rev Neurobiol; 2007 Aug 15; 79():99-126. PubMed ID: 17531839
    [Abstract] [Full Text] [Related]

  • 59. Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis.
    Kopadze T, Dehmel T, Hartung HP, Stüve O, Kieseier BC.
    Arch Neurol; 2006 Nov 15; 63(11):1572-8. PubMed ID: 17101825
    [Abstract] [Full Text] [Related]

  • 60. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL, Wiendl H.
    Nat Clin Pract Neurol; 2008 Jul 15; 4(7):384-98. PubMed ID: 18578001
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.